Title:
INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
Document Type and Number:
WIPO Patent Application WO/2014/152536
Kind Code:
A3
Abstract:
The present invention is directed to compounds encompassed by the Formula (I), pharmaceutical compositions thereof, methods for inhibiting LTA-4 hydrolase, and methods for the treatment of a disease and disorder which is ameliorated by the inhibition of LTA4-h activity. Non-limiting examples of such diseases and conditions include inflammatory and autoimmune diseases and disorders.
Inventors:
GUILFORD WILLIAM (US)
DAVEY DAVID (US)
DAVEY DAVID (US)
Application Number:
PCT/US2014/027449
Publication Date:
November 27, 2014
Filing Date:
March 14, 2014
Export Citation:
Assignee:
CELTAXSYS INC (US)
International Classes:
A61K31/395
Domestic Patent References:
| WO2012125832A2 | 2012-09-20 |
Foreign References:
| US20040198777A1 | 2004-10-07 | |||
| US20120302610A1 | 2012-11-29 |
Other References:
See also references of EP 2968265A4
Attorney, Agent or Firm:
HODA, Mahreen, Chaudhry et al. (P.C.484 Groton Roa, Westford MA, US)
Download PDF: